These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19769558)

  • 1. Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus.
    Cheung NW; Conn JJ; d'Emden MC; Gunton JE; Jenkins AJ; Ross GP; Sinha AK; Andrikopoulos S; Colagiuri S; Twigg SM;
    Med J Aust; 2009 Sep; 191(6):339-44. PubMed ID: 19769558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
    Pickup JC; Freeman SC; Sutton AJ
    BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review.
    Westall SJ; Narayanan RP; Watmough S; Irving G; Furlong N; McNulty S; Bujawansa S; Hardy K
    Clin Med (Lond); 2022 May; 22(3):257-265. PubMed ID: 35443970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
    Karagiannis T; Paschos P; Paletas K; Matthews DR; Tsapas A
    BMJ; 2012 Mar; 344():e1369. PubMed ID: 22411919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
    Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
    Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are elderly patients with diabetes being overtreated in French long-term-care homes?
    Bouillet B; Vaillant G; Petit JM; Duclos M; Poussier A; Brindisi MC; Vergès B
    Diabetes Metab; 2010 Sep; 36(4):272-7. PubMed ID: 20363171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.
    Miller ME; Bonds DE; Gerstein HC; Seaquist ER; Bergenstal RM; Calles-Escandon J; Childress RD; Craven TE; Cuddihy RM; Dailey G; Feinglos MN; Ismail-Beigi F; Largay JF; O'Connor PJ; Paul T; Savage PJ; Schubart UK; Sood A; Genuth S;
    BMJ; 2010 Jan; 340():b5444. PubMed ID: 20061360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HbA1c: target value should remain 7%].
    Soeters MR; Hoekstra JB; de Vries JH
    Ned Tijdschr Geneeskd; 2010; 154():A2113. PubMed ID: 20619040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
    Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
    Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
    BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change of HbA1c reporting to the new SI units.
    Jones GR; Barker G; Goodall I; Schneider HG; Shephard MD; Twigg SM
    Med J Aust; 2011 Jul; 195(1):45-6. PubMed ID: 21728944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1C) without causing weight gain or increased hypoglycaemia.
    Rosenstock J; Rendell MS; Gross JL; Fleck PR; Wilson CA; Mekki Q
    Diabetes Obes Metab; 2009 Dec; 11(12):1145-52. PubMed ID: 19758359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PREDICTIVE- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort.
    Lüddeke HJ; Sreenan S; Aczel S; Maxeiner S; Yenigun M; Kozlovski P; Gydesen H; Dornhorst A;
    Diabetes Obes Metab; 2007 May; 9(3):428-34. PubMed ID: 17391171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Algorithm Dedicated to Blood Glucose Monitoring in Insulin-Treated Elderly Dependent People With Diabetes.
    Grino M; Loundou A; Boucekine M; Alitta Q; Oliver C
    J Diabetes Sci Technol; 2019 Mar; 13(2):410-412. PubMed ID: 30537870
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.
    Lund SS; Tarnow L; Frandsen M; Nielsen BB; Hansen BV; Pedersen O; Parving HH; Vaag AA
    BMJ; 2009 Nov; 339():b4324. PubMed ID: 19900993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management.
    Bailey CJ; Blonde L; Del Prato S; Leiter LA; Nesto R;
    Diab Vasc Dis Res; 2009 Oct; 6(4):283-7. PubMed ID: 20368223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients.
    Cosson E; Hamo-Tchatchouang E; Dufaitre-Patouraux L; Attali JR; Pariès J; Schaepelynck-Bélicar P
    Diabetes Metab; 2009 Sep; 35(4):312-8. PubMed ID: 19560388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycaemic control: a balancing act or a different approach?
    Fava S
    Curr Diabetes Rev; 2014 Mar; 10(2):124-30. PubMed ID: 24745817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.